What may be gained from standard photocoagulation during early worsening of diabetic retinopathy? An observational study in type-1 diabetic patients after tightening of glycaemic control

Diabetes and Metabolism

Volumn 27, Issue 3, 2001, Pages 366-371

  Chantelau, E ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Complications; Diabetes mellitus; Glycaemic control; JGF 1; Metabolic control; Proliferative retinopathy

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; DIABETIC RETINOPATHY; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN DETERMINATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LASER COAGULATION; MALE; OBSERVATION; RETINA MACULA EDEMA; TREATMENT OUTCOME; VISUAL ACUITY;

ADOLESCENT; ADULT; AGE OF ONSET; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; DIABETIC NEUROPATHIES; DIABETIC RETINOPATHY; DISEASE PROGRESSION; FOLLOW-UP STUDIES; GERMANY; HEMOGLOBIN A, GLYCOSYLATED; HOSPITALS, UNIVERSITY; HUMANS; HYPERTENSION; LIGHT COAGULATION; PREVALENCE; PROTEINURIA; RETROSPECTIVE STUDIES; TIME FACTORS; VISUAL ACUITY; VITRECTOMY;

EID: 0034942101     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Diabetic retinopathy. A clinical overview
2. Risk factors for high-risk proliferative diabetic retinopathy and severe visual loss: ETDRS report nr. 18
3. Early worsening of diabetic retinopathy in the diabetes control and complications trial
4. Effects of intensified insulin treatment on various leasions of diabetic retinopathy
5. Transient proliferative diabetic retinopathy during intensified insulin treatment
6. Conversion, control and complications: A good prognosis for complications develloping with tightening of control
7. Rapid deterioration of diabetic retinopathy during treatment with continuous subcutaneous insulin infusion
8. Irreversible progression of severe retinopathy in young type-1 insulin-dependent diabetes mellitus patients after improved control
9. Association of blindness to intensification of glycemic control in insulin-dependent diabetes mellitus
10. Full panretinal photocoagulation and early vitrectomy improve prognosis of florid diabetic retinopathy
11. How effective are treatments for diabetic retinopathy?
12. Epidemiology of proliferative diabetic retinopathy
13. Elevation of serum IGF-1 rather than sex steroids precedes proliferative diabetic retinopathy in Mauriac's syndrome
14. Acute painful diabetic neuropathy precipitated by strict glycaemic control
15. Stadienbezogene therapie der diabetischen retinopathie
16. Early photocoagulation for diabetic retinopathy: ETDRS report nr.9
17. Fundus photographic risk factors for progression of diabetic retinopathy: ETDRS report nr.12
18. Guidelines for the diagnosis and outpatient management of diabetic peripheral neuropathy
19. Cigarette-smoking as a risk factor for macroproteinuria and proliferative retinopathy in type-1 (insulin-dependent) diabetes
20. Fundus Polaroid screening for diabetic retinopathy: Is one print per patient enough?
21. Observations on the decay of glycated hemoglobin HbAlc in diabetic patients
22. Relationship between glycohemoglobin (GHB) and mean blood glucose (MBG) in the diabetes control and complications trial
23. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
24. Macular oedema and retinal neovascularisation in juvenile diabetics
25. Classification of diabetic retinopathy, with therapeutic implications
26. Florid diabetic retinopathy and its response to treatment by photocoagulation or pituitary ablation
27. Combined modified grid and panretinal photocoagulation for diffuse diabetic macular edema and proliferative diabetic retinoparthy
28. Evidence that upregulation of serum IGF-1 concentration can trigger acceleration of diabetic retinopathy
29. Insulin-induced vascular endothelial growth factor expression in retina
30. Systemic levels contribute significantly to increased intraocular IGF-I, IGF-II and IGF-BP3 in proliferative diabetic retinopathy
31. Cotherapy with recombinant human insulin-like growth factor 1 and insulin improves glycemic control in type-1 diabetes
32. Regulation of vascular endothelial growth factor-dependent retinal neovascularization by insulin-like growth factor-1 receptor
33. The efficacy of octreotide in the therapy of severe nonproliferative and early proliferative diabetic retinopathy
34. Suramin decreases circulating levels of insulin-like growth factor-1
35. Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant
36. Treating 20/20 eyes with diabetic macular edema